Citigroup Inc Atai Life Sciences N.V. Transaction History
Citigroup Inc
- $150 Billion
- Q1 2024
A detailed history of Citigroup Inc transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Citigroup Inc holds 842 shares of ATAI stock, worth $1,119. This represents 0.0% of its overall portfolio holdings.
Number of Shares
842
Previous 3,233
73.96%
Holding current value
$1,119
Previous $4,000
75.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ATAI
# of Institutions
96Shares Held
13.1MCall Options Held
229KPut Options Held
114K-
Morgan Stanley New York, NY2.67MShares$3.55 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.22MShares$2.95 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.4MShares$1.86 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0794KShares$1.06 Million0.0% of portfolio
-
Brown University719KShares$955,6050.61% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $221M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...